Formoterol Turbuhaler®for as-needed therapy in patients with mild acute exacerbations of COPD
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 95 (11) , 917-921
- https://doi.org/10.1053/rmed.2001.1172
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Pharmacological Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseDrugs & Aging, 1998
- Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstructionEuropean Respiratory Journal, 1997
- The Use of Bronchodilators in Stable Chronic Obstructive Pulmonary DiseasePulmonary Pharmacology & Therapeutics, 1997
- In Vitro Properties of Pressurized Metered Dose Inhalers With and Without Spacer DevicesJournal of Aerosol Medicine, 1995
- Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lungEuropean Journal of Pharmacology, 1994
- FormoterolDrugs, 1991
- Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects.Thorax, 1987
- Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.Thorax, 1983
- Assessment of optimum dose of inhaled terbutaline in patients with chronic asthma: The use of simple, cumulative dose-response curvesRespiratory Medicine, 1982